HPV DNA Screen
Private HPV DNA Screen in London for £128, detecting HPV genetic material with specialist results expected in around 3 business days.
Turnaround time
3 business days
Biomarkers count
1
Book your test
Choose Service Type
Professional phlebotomist comes to you
+ £{{ home_visit_fee }}
Visit our clinic for your test
{{ clinic_visit_fee > 0 ? '+ £' + clinic_visit_fee : 'Free' }}
Home Visit Details
Home visits require at least 24 hours notice.
Select a clinic: Sorting by distance…
{{ clinicAddress(clinic) }}
{{ clinicAddress(selectedClinic) }}
Select a date
Select an hour
Available time slots: {{ timeSlots.length}}
Overview of the HPV DNA Screen
The HPV DNA Screen is a molecular test used to detect genetic material from human papillomavirus, or HPV, in an appropriate cervical or vaginal specimen.
The test contains 1 laboratory profile: HPV DNA Screen.
HPV is a large group of viruses transmitted mainly through intimate skin-to-skin and sexual contact.
HPV infection is extremely common.
Most sexually active people will encounter one or more HPV types during their lifetime, often without ever knowing because the infection usually causes no symptoms.
HPV types differ in their clinical significance.
Certain types are classified as high-risk HPV because persistent infection is associated with cervical precancerous changes and cervical cancer.
Other types have much lower cancer-associated risk and may be associated with benign genital warts.
An HPV DNA test detects viral genetic material.
A positive result does not mean that cervical cancer is present.
In most people, HPV infection is controlled or cleared by the immune system without causing significant disease.
The principal concern is persistent infection with a high-risk HPV type over time.
Persistence increases the likelihood that abnormal cervical-cell changes can develop.
HPV DNA testing and cervical cytology answer different questions.
HPV testing identifies viral genetic material, whereas cervical cytology examines cervical cells for morphological abnormalities.
Depending on the assay and laboratory pathway, HPV testing may identify high-risk HPV collectively or provide individual information about selected types such as HPV 16 and HPV 18.
The precise types reported depend on the methodology used.
A positive result may therefore lead to additional cervical cytology, repeat HPV testing or colposcopy depending on the HPV type, age, previous screening history and other clinical information.
What Does the HPV DNA Screen Test Check?
This test contains 1 laboratory profile.
HPV DNA Screen
Detects human papillomavirus DNA using molecular analysis. The clinical significance depends on the HPV types included in the assay, whether a high-risk type is detected and whether infection persists.
Who May Benefit From the HPV DNA Screen?
HPV DNA testing may be useful for people requiring private molecular assessment of cervical HPV infection or follow-up of a previous HPV result.
People undergoing cervical-health assessment - High-risk HPV is central to modern cervical-screening pathways.
People with a previous positive high-risk HPV result - Repeat testing may be used to determine whether infection remains detectable.
People with previous cervical-cell abnormalities - HPV status can contribute to determining appropriate follow-up.
People who have missed or delayed routine cervical screening - Private testing may provide additional access, although it should complement rather than undermine established screening pathways.
People undergoing follow-up after treatment for cervical abnormalities - HPV testing can contribute to surveillance according to clinical guidance.
People who are immunocompromised and require specialist cervical surveillance - Reduced immune clearance can increase the likelihood of persistent HPV.
People with a previous uncertain or incomplete HPV result - Repeat testing may help clarify current viral status.
People specifically advised to obtain HPV DNA testing - Testing can be arranged when requested by a GP, gynaecologist or cervical-screening clinician.
People seeking private HPV assessment after a change in sexual circumstances - Testing can detect current viral DNA but cannot determine exactly when infection was acquired.
How to Prepare
An HPV DNA result should never be interpreted as a cancer diagnosis.
The purpose of screening is to identify viral risk that may require surveillance or further cervical assessment before significant disease develops.
Symptoms and Reasons to Consider the HPV DNA Screen Test
High-risk cervical HPV usually causes no symptoms, which is why screening is important.
No symptoms but cervical screening is due - High-risk HPV infection can be present without any physical symptoms.
A previous positive HPV result - Repeat testing may determine whether infection remains detectable over time.
A previous abnormal cervical cytology result - HPV status may help guide follow-up.
Previous treatment for cervical cell abnormalities - Molecular HPV testing can form part of post-treatment surveillance.
A history of persistent high-risk HPV - Ongoing viral detection may require closer cervical monitoring.
Immunosuppression with a need for specialist cervical surveillance - Immune suppression can reduce the likelihood of spontaneous HPV clearance.
A previous cervical-screening result requiring further investigation - HPV testing may contribute to the next stage of assessment.
A request for private cervical HPV assessment - Molecular testing can determine whether HPV DNA included within the assay is currently detectable.
High-risk cervical HPV generally does not cause pain, discharge or bleeding by itself.
Unexplained bleeding after sex, persistent abnormal vaginal bleeding, pelvic pain or other gynaecological symptoms require appropriate clinical assessment and should not be managed solely with an HPV screening test.
How to Book Your HPV DNA Screen Test
HPV DNA testing requires an appropriate cervical or vaginal specimen.
Choose the HPV DNA Screen
Select the molecular HPV DNA Screen and review the specimen requirements.
Select your sample collection option
Arrange the appropriate clinician-led collection or another approved specimen pathway available for the assay.
Attend your appointment
The required cervical or vaginal specimen is collected using the laboratory-approved device.
Laboratory analysis
Molecular analysis is performed to detect HPV DNA included within the laboratory assay.
Receive your results securely
Your authorised HPV report is delivered securely with appropriate follow-up advised if high-risk HPV is detected.
When Will I Receive My Results?
The expected turnaround for the HPV DNA Screen is approximately 3 business days after an acceptable specimen reaches the laboratory.
The laboratory must first process the cervical or vaginal specimen, perform molecular HPV analysis and complete its quality-control and authorisation procedures.
Turnaround begins from laboratory receipt rather than necessarily from the time your sample is collected.
Where the pathway requires additional genotyping, reflex cytology or another follow-up investigation, the overall time before the complete clinical picture is available can be longer.
Sample-quality issues or insufficient cellular material can also occasionally require repeat collection.
Understanding Your Results
A negative result means HPV DNA from the types targeted by the assay was not detected in the submitted specimen.
Where the assay is designed for high-risk HPV, a negative result is generally reassuring because current detectable infection with those high-risk types has not been demonstrated.
A positive result means HPV genetic material was detected.
The significance depends on the HPV type and the laboratory's reporting method.
Detection of high-risk HPV does not mean that cervical cancer is present.
Most HPV infections clear or become undetectable naturally.
Persistent infection is more clinically important than one isolated positive result.
If HPV 16, HPV 18 or another higher-risk type is individually reported, the recommended follow-up may differ according to current cervical-screening guidance.
Depending on the circumstances, follow-up can involve cervical cytology, repeat HPV testing or colposcopy.
An HPV result also cannot determine when the infection was acquired or which partner transmitted it because HPV can remain latent or intermittently detectable for prolonged periods.
Why Book With London Blood Tests?
Private HPV DNA testing in London - Access confidential molecular HPV assessment privately.
Direct viral DNA detection - The test identifies HPV genetic material rather than relying on antibodies.
Relevant to cervical-health assessment - Persistent high-risk HPV is an important risk factor for cervical precancerous change.
Clear distinction from cancer diagnosis - A positive HPV result does not mean cancer is present.
Useful during follow-up - Repeat HPV testing can contribute to monitoring persistent infection.
Specialist molecular analysis - Samples undergo dedicated laboratory DNA testing.
Secure reporting - Receive your authorised HPV result confidentially.
Clear pricing - The HPV DNA Screen costs £128.
Private HPV DNA Screen in London
London Blood Tests provides private HPV DNA screening in London for people requiring molecular assessment of human papillomavirus infection.
The test costs £128 and contains one laboratory profile: HPV DNA Screen.
An appropriate cervical or vaginal specimen is required.
Results are expected approximately 3 business days after laboratory receipt.
A positive result identifies HPV DNA but does not diagnose cervical cancer, and the appropriate follow-up depends on the type detected, previous screening history and cervical findings.